oxidopamine has been researched along with Deglutition Disorders in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Deglutition Disorders: Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciucci, MR | 1 |
| Russell, JA | 1 |
| Schaser, AJ | 1 |
| Doll, EJ | 1 |
| Vinney, LM | 1 |
| Connor, NP | 1 |
1 other study available for oxidopamine and Deglutition Disorders
| Article | Year |
|---|---|
Tongue force and timing deficits in a rat model of Parkinson disease.
Topics: Animals; Basal Ganglia; Deglutition Disorders; Disease Models, Animal; Male; Medial Forebrain Bundle | 2011 |